During the past decade, Van der Veer Institute for Parkinson's Disease and Movement Disorders conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Van der Veer Institute for Parkinson's Disease and Movement Disorders" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Van der Veer Institute for Parkinson's Disease and Movement Disorders" are "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Multiple System Atrophy" (1 trials), "Neurogenic Orthostatic Hypotension" (1 trials), "Non-Diabetic Autonomic Neuropathy" (1 trials) and "Non-diabetic Neuropathy" (1 trials). Many other conditions were trialed in "Van der Veer Institute for Parkinson's Disease and Movement Disorders" in a lesser frequency.

Most popular intervention types in "Van der Veer Institute for Parkinson's Disease and Movement Disorders" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Droxidopa" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Van der Veer Institute for Parkinson's Disease and Movement Disorders" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Van der Veer Institute for Parkinson's Disease and Movement Disorders". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Van der Veer Institute for Parkinson's Disease and Movement Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Van der Veer Institute for Parkinson's Disease and Movement Disorders, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".